Suppr超能文献

比较减少头颈部癌症吞咽相关结构剂量的方法。

Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.

机构信息

Department of Radiation Oncology, University of Alabama at Birmingham, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):462-7. doi: 10.1016/j.ijrobp.2009.05.020. Epub 2009 Jul 4.

Abstract

INTRODUCTION

Emerging data suggest that reduction of dose to the larynx and pharyngeal constrictor may lower the risk of swallowing complications such as long-term gastrostomy dependence and aspiration. Organ avoidance becomes difficult when the primary tumor or involved nodes are present at the level of the larynx.

MATERIALS AND METHODS

Fifteen patients with Stage III-IV squamous cell carcinoma of the head and neck with high-dose target volume at the level of the larynx (but not involving the glottic larynx) were planned with whole-field IMRT (WF-IMRT), as well as a low anterior neck field dynamically matched to an IMRT plan (D-SCLV). Plans were compared with respect to coverage of targets and sparing of normal tissues including the larynx, inferior pharyngeal constrictor (IPC), parotid, and cord.

RESULTS

There was no significant difference between the two techniques in coverage of the high- or intermediate-dose planning target volumes (PTVs). Coverage of the elective nodal PTV was inferior with the D-SCLV technique, with a mean of 96.5% vs. 86.3% of the volume receiving the prescription dose (p = 0.001) compared with WF-IMRT plans. However, the D-SCLV technique significantly reduced mean dose to the larynx (43.7 vs. 46.7 Gy, p = 0.05) and IPC (39.1 vs. 46.1 Gy, p = 0.002). There was no significant difference in dose to the parotid or cord.

CONCLUSION

Given the steep dose responses seen in studies examining the association between swallowing toxicity and dose to the larynx and IPC, dose reductions using the D-SCLV technique may be clinically significant.

摘要

简介

新出现的数据表明,减少喉和咽缩肌的剂量可能会降低吞咽并发症的风险,例如长期胃造口依赖和吸入。当原发肿瘤或受累淋巴结位于喉部水平时,器官回避变得困难。

材料和方法

15 例 III-IV 期头颈部鳞状细胞癌患者,喉部高剂量靶区(但不包括声门喉)采用全野调强放疗(WF-IMRT),以及与调强计划动态匹配的低前颈部野(D-SCLV)进行计划。比较了两种技术在靶区覆盖和正常组织保护方面的情况,包括喉、下咽缩肌(IPC)、腮腺和声带。

结果

两种技术在高剂量或中剂量计划靶区(PTV)的覆盖方面没有显著差异。D-SCLV 技术的选择性淋巴结 PTV 覆盖较差,其处方剂量(p = 0.001)的体积接受率为 96.5%,而 WF-IMRT 计划为 86.3%。然而,D-SCLV 技术显著降低了喉(43.7 对 46.7 Gy,p = 0.05)和 IPC(39.1 对 46.1 Gy,p = 0.002)的平均剂量。腮腺或声带的剂量没有显著差异。

结论

鉴于研究中观察到吞咽毒性与喉和 IPC 剂量之间的关联的陡峭剂量反应,D-SCLV 技术的剂量降低可能具有临床意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验